Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes.
about
Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetesImprovement of both fasting and postprandial glycemic control by the two-step addition of miglitol and mitiglinide to basal insulin therapy: a pilot study.Additive effects of miglitol and anagliptin on insulin-treated type 2 diabetes mellitus: a case study.Four-Point Preprandial Self-Monitoring of Blood Glucose for the Assessment of Glycemic Control and Variability in Patients with Type 2 Diabetes Treated with Insulin and Vildagliptin.Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review.
P2860
Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes.
@ast
Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes.
@en
type
label
Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes.
@ast
Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes.
@en
prefLabel
Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes.
@ast
Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes.
@en
P2860
P1433
P1476
Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes.
@en
P2093
Mitsuhiko Noda
Miyako Kishimoto
P2860
P2888
P356
10.1007/S13300-012-0011-X
P577
2012-09-28T00:00:00Z